Keywords: sanofi, expands, access, immunogen, tap, technology, firm

Sanofi expands access to ImmunoGen's TAP technology

Article | 18 August 2008

Print This

US firm ImmunoGen says that French drug major Sanofi-Aventis has exercised its option under a 2006 agreement for expanded access to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in